A bill to clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers; to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

H.R. 2672 — A bill to clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers; to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

By Mr. GERLACH (for himself and Mr. Altmire), H5660 [27JY]

Cosponsors added, H6626 [5OC], H6674 [6OC], H6922 [13OC], H7009 [24OC], H7069 [25OC], H7627 [15NO], H7830 [17NO], H7892 [18NO], H7929 [29NO], H8125 [2DE], H8188 [6DE], H8262 [7DE], H8881 [13DE]